↓ Skip to main content

Treatment of steroid-resistant nephrotic syndrome in children: new guidelines from KDIGO

Overview of attention for article published in Pediatric Nephrology, October 2012
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
103 Dimensions

Readers on

mendeley
147 Mendeley
citeulike
2 CiteULike
Title
Treatment of steroid-resistant nephrotic syndrome in children: new guidelines from KDIGO
Published in
Pediatric Nephrology, October 2012
DOI 10.1007/s00467-012-2304-8
Pubmed ID
Authors

Rebecca M. Lombel, Elisabeth M. Hodson, Debbie S. Gipson

Abstract

Kidney Disease: Improving Global Outcomes (KDIGO) recently published the clinical practice guideline on glomerulonephritis (GN) to assist the practitioner caring for patients with GN. Chapter 4 of the guideline focuses on managing children aged 1-18 years with steroid-resistant nephrotic syndrome (SRNS), defined by an inability to achieve complete remission with corticosteroid therapy. Guideline development followed a thorough evidence review, and management recommendations and suggestions were based on the best available evidence. Limitations of the evidence, including the paucity of large-scale randomized controlled trials, are discussed. This article provides both the guideline recommendations and a brief review of relevant treatment trials related to each recommendation. This précis serves as a summary of the complete guidelines recently published.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 147 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Malaysia 1 <1%
Serbia 1 <1%
Unknown 144 98%

Demographic breakdown

Readers by professional status Count As %
Student > Postgraduate 18 12%
Other 16 11%
Student > Ph. D. Student 16 11%
Student > Master 16 11%
Student > Bachelor 14 10%
Other 37 25%
Unknown 30 20%
Readers by discipline Count As %
Medicine and Dentistry 78 53%
Pharmacology, Toxicology and Pharmaceutical Science 11 7%
Nursing and Health Professions 5 3%
Agricultural and Biological Sciences 4 3%
Biochemistry, Genetics and Molecular Biology 3 2%
Other 10 7%
Unknown 36 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 February 2018.
All research outputs
#17,667,907
of 22,681,577 outputs
Outputs from Pediatric Nephrology
#2,915
of 3,520 outputs
Outputs of similar age
#125,713
of 172,607 outputs
Outputs of similar age from Pediatric Nephrology
#16
of 22 outputs
Altmetric has tracked 22,681,577 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,520 research outputs from this source. They receive a mean Attention Score of 4.9. This one is in the 11th percentile – i.e., 11% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 172,607 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one is in the 22nd percentile – i.e., 22% of its contemporaries scored the same or lower than it.